Skip to main content

Table 1 Population characteristics (N = 1749)

From: Role of the 2018 American Thyroid Association statement on postoperative hypoparathyroidism: a 5-year retrospective study

Index N %
Age (years)* 41.52 ± 11.52
< 55/≥ 55 years 1532/217 87.6/12.4
Male/female 491/1258 28.1/71.9
131I ablation 940 53.7
BMI* 23.18 ± 3.91
< 24/≥ 24 1126/623 64.4/35.6
Hypertension 144 8.2
Diabetes 46 2.6
Hypothyroidism 26 1.5
Hyperthyroidism 47 2.7
HD 387 22.1
NG 908 51.9
Tumor located at isthmus 85 4.9
Bilaterality 248 14.2
Multifocality 421 24.1
Tumor size (mm)* 13.66 ± 8.94
Capsular invasion 366 20.9
Minor ETE 170 9.7
Major ETE 100 5.7
UCND/BCND 403/1346 23.0/77.0
ULND/BLND 328/45 18.8/2.6
Carbon nanoparticles 1287 73.6
Tx/T1a/T1b/T2/T3a/T3b/T4a/T4b 10/652/493/118/241/160/73/2 0.6/37.3/28.2/6.7/13.8/9.1/4.2/0.1
Nx/N0/N1a/N1b 12/857/525/355 0.7/49.0/30.0/20.3
M0/M1 1742/7 99.6/0.4
  1. BMI, Body mass index; HD, Hashimoto’s thyroiditis; NG, Nodular goiter; ETE, extrathyroidal extension; UCND, unilateral central neck dissection; BCND, bilateral central dissection; ULND, unilateral lateral neck dissection; BLND, bilateral lateral neck dissection
  2. *Data presented as mean ± standard deviation